Alanine aminotransferase |
(ALT) |
Androgen receptors |
(ARs) |
Aspartate aminotransferase |
(AST) |
Atrazine |
(ATZ) |
Body mass index |
(BMI) |
Plasticizers bisphenol A |
(BPA) |
Bisphenol A |
(BPA) |
Confidence interval |
(CI) |
Credible interval |
(CrI) |
Cypermethrin |
(CYP) |
Cytochrome P450 |
(CYP) |
Organochlorines dichlorodiphenyltrichloroethane |
(DDT) |
Phthalates di-2-ethylhexyl phthalate |
(DEHP) |
Developmental Origins of Health and Disease |
(DOHaD) |
Estrone |
(E1) |
17-β-estradiol |
(E2) |
Estriol |
(E3) |
European Chemicals Agency |
(ECHA) |
Endocrine-disrupting chemicals |
(EDCs) |
Ethinylestradiol |
(EE2) |
European Food Safety Authority |
(EFSA) |
Protection Agency |
(EPA) |
Estrogen receptors |
(ERα and ERβ) |
Free Fatty Acids |
(FFAs) |
Farnesoid X α receptor |
(FXRα) |
Gamma-glutamyl transferase |
(GGT) |
Hepatitis C Virus virus |
(HCV) |
High-density lipoprotein |
(HDL) |
Janus kinase 2/Signal Transducer and Transcription Activator 5 |
(JAK2/STAT5) |
Lipid accumulation product |
(LAP) |
Low birth weight |
(LBW) |
Liver X receptors α and β |
(LXR) |
Steatohepatitis associated with metabolic dysfunction |
(MASH), |
Metabolic dysfunction-associated steatotic liver disease |
(MASLD) |
Mono-(2-ethylhexyl) phthalate |
(MEHP) |
Monoethyl phthalate |
(MEP) |
Mono-(2-ethylhexyl) phthalate |
(MEPH) |
Metabolite mono-(2-ethylhexyl) phthalate |
(MEPH) |
Nonalcoholic fatty liver disease |
(NAFLD) |
Non-alcoholic Steatosteato-hepatitis |
(NASH) |
Dioxin-like (DL) and non-dioxin-like |
(NDL) |
Dioxin-like (DL) and non-dioxin-like |
(NDL) |
Nonylphenols |
(NPs) |
Occhlorinated dibenzodioxin |
(OCDD) |
Odds ratio |
(OR) |
Polycyclic aromatic hydrocarbons |
(PAHs) |
Polybrominated diphenyl ethers |
(PBDEs) |
2-polybrominated diphenyl ethers |
(PBDEs) |
Polychlorinated biphenyls |
(PCBs) |
Perfluoroalkyl substances |
(PFAS) |
Fluorinated chemicals |
(PFCs) |
Perfluorohexane sulfonic acid |
(PFHxS) |
Perfluorooctanoic acid |
(PFOA) |
Organotins tributyltin polyfluoroalkyls and/or perfluorooctane sulfonate |
(PFOS) |
Perfluorooctane sulfonate |
(PFOS) |
Persistent Organic Pollutants |
(POPs) |
Peroxisome proliferators |
(PPARs) |
Peroxisome proliferator-activated γ receptor |
(PPARγ) |
Progesterone receptors |
(PRs) |
Retinoic receptor isoforms |
(RARα and RARγ) |
Retinoid X receptors |
(RXRα, RXRβ, and RXRγ) |
Retinoid α X receptor |
(RXRα) |
Steroid receptor coactivator complexes |
(SRCs) |
Type 2 diabetes mellitus |
(T2DM) |
Triacylglyceride |
(TAG) |
Thyroid receptors |
(TR) |
Thyroid α receptor isoforms |
(TRα) |
UDP-glucuronosyltransferase |
(UGT) |
Visceral adiposity index |
(VAI) |
Very Low-Density Lipoprotein |
VLDL |